Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomonitoring Reveals the Transition from Legacy to Emerging PFAS in Subtropical Estuaries: Dual Roles of Usage Shift and Environmental Parameters.

Environmental science & technology·2026
Same author

Correction to "Ecological Impacts of Deep-Sea Mining Waste on Marine Algae and Copepod <i>Tigriopus californicus</i>".

Environmental science & technology·2026
Same author

Revealing Single-Cell Heterogeneity of Labile Cu(I) Accumulation and Metabolism in Microalgae by Image-Enabled Flow Cytometry.

Environmental science & technology·2026
Same author

Mechanistic Acute-to-Chronic Extrapolation through Sediment Toxicokinetic-Toxicodynamic Modeling.

Environmental science & technology·2026
Same author

Size-dependent translocation of polystyrene nanoplastics across biological barriers in mammals.

Nature communications·2025
Same author

Divergent selection, recombination variability, and noncoding introgression drive speciation and adaptation in threadfin Eleutheronema.

Communications biology·2025

Related Experiment Video

Updated: May 16, 2026

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems
13:16

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems

Published on: December 24, 2014

Advancing Toxicokinetic-Toxicodynamic Modeling To Assess Kinetic Bioavailability in Sediments.

Zhi Lin1, Wenze Xiao1, Qiao-Guo Tan1

  • 1State Key Laboratory of Marine Environmental Science, Fujian Provincial Key Laboratory for Coastal Ecology and Environmental Studies, Key Laboratory of the Ministry of Education for Coastal and Wetland Ecosystem, College of the Environment and Ecology, Xiamen University, Xiamen, Fujian 361102, China.

Environmental Science & Technology
|March 4, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces stable isotope tracing for toxicokinetic-toxicodynamic (TKTD) models in sediments. This method improves ecological risk assessments by linking copper uptake, elimination, and clam survival.

Keywords:
Cu speciationProcess-based modelRuditapes philippinarumsediment risk assessment

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Related Experiment Videos

Last Updated: May 16, 2026

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems
13:16

A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems

Published on: December 24, 2014

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Area of Science:

  • Environmental Toxicology
  • Ecotoxicology
  • Aquatic Toxicology

Background:

  • Traditional sediment risk assessments use fixed endpoints, missing dynamic exposure-effect interactions.
  • Toxicokinetic-toxicodynamic (TKTD) models link exposure, internal dose, and effects but lack sediment application methods.
  • High-quality kinetic data for sediment TKTD models is limited by tracing method availability.

Purpose of the Study:

  • To develop a novel stable isotope tracing approach for sediment TKTD studies.
  • To integrate bioaccumulation and toxicity in a sediment TKTD model for copper (Cu).
  • To establish mechanistic bioavailability benchmarks for chronic risk assessment in estuarine ecosystems.

Main Methods:

  • Pre-labeled clams (Ruditapes philippinarum) with stable 65Cu in water before sediment exposure.
  • Simultaneously tracked 65Cu elimination and ambient Cu uptake in clams exposed to Cu-amended sediments.
  • Developed a sediment TKTD model integrating bioaccumulation and clam survival across varying Cu bioavailability.

Main Results:

  • Established a sediment TKTD model demonstrating species-specific Cu elimination and tolerance in clams.
  • Identified a Michaelis-Menten relationship between Cu uptake and bioavailable Cu.
  • Derived chronic thresholds: DGT-Cu based LC50-chronic = 42 μg L-1 and NECDGT = 34 μg L-1.

Conclusions:

  • Stable isotope tracing enables TKTD modeling in sediments, advancing process-based ecological risk assessment.
  • The developed framework is transferable for evaluating contaminant bioavailability in estuarine environments.
  • Mechanistic bioavailability benchmarks provide improved chronic thresholds for sediment risk management.